
Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle
Last reviewed: April 2026
Quick answer: Plantar fat pad atrophy is the thinning and degeneration of the natural cushioning layer on the bottom of the foot, causing severe pain with walking on hard surfaces — especially without shoes. It’s most common in older adults, thin individuals, and those who’ve had multiple corticosteroid injections in the foot. Treatment focuses on cushioning with specialized insoles, padding, and footwear modification rather than restoring the lost tissue.
If you’ve noticed that walking barefoot on hard floors has become genuinely painful as you’ve gotten older — or if you’ve developed severe heel or ball-of-foot pain that doesn’t fit the typical plantar fasciitis pattern — plantar fat pad atrophy may be the culprit. The plantar fat pad is one of the most underappreciated structures in the foot: a shock-absorbing layer of specialized adipose tissue that protects the underlying bones and joints with every step. When it thins, patients describe walking on pebbles or bones.
This is a condition where diagnosis matters enormously for treatment — fat pad atrophy will not respond to stretching, injections, or plantar fasciitis protocols. Once you understand what’s happening, the management is logical and highly effective.
What Is the Plantar Fat Pad?
The plantar fat pad is a specialized cushioning structure on the sole of the foot, composed of a complex network of fibrous septae (fibrous walls) that partition the fat into small sealed chambers — similar to bubble wrap. This architecture allows the pad to bear load, distribute pressure, and absorb shock without simply squishing flat under body weight. It is not ordinary subcutaneous fat; its unique microarchitecture gives it mechanical properties far superior to simple adipose tissue.
There are two primary fat pad regions: the heel fat pad (calcaneal fat pad), located directly under the calcaneus, which is the thickest and most mechanically complex, and the metatarsal fat pad (forefoot fat pad), located under the metatarsal heads, which absorbs forefoot impact during the push-off phase of gait. Both can undergo atrophy, producing distinct symptom patterns.
Symptoms of Fat Pad Atrophy
The symptom profile of fat pad atrophy is characteristic and helps distinguish it from plantar fasciitis, metatarsalgia, or neuropathy.
Heel Fat Pad Atrophy
- Severe pain directly on the heel when walking on hard surfaces, especially barefoot
- Immediate pain from first steps — unlike plantar fasciitis which is worst with first steps after rest, fat pad pain is present throughout weight bearing and does not improve with walking
- Relief with thick-soled shoes or heel cups — the most distinguishing feature; adding cushion dramatically reduces pain
- Visibly thin heel pad — In advanced cases, bony prominences of the calcaneus may be visible or palpable through the thinned skin
- Skin bruising or callus formation — The skin compensates for lost pad with callus development over bony prominences
Metatarsal (Forefoot) Fat Pad Atrophy
- “Walking on marbles” sensation — Patients describe feeling the metatarsal heads directly with every step
- Forefoot pain with prolonged standing or walking — Worsens through the day with cumulative load
- Callus formation under individual metatarsal heads — The skin thickens over the exposed bony prominences
- Pain relief with metatarsal padding — Metatarsal pads or bars redistribute load away from the affected metatarsal heads
- Association with hammertoes and bunions — Toe deformities cause the fat pad to migrate distally, exposing the metatarsal heads
Key takeaway: The most important distinguishing feature between plantar fasciitis and heel fat pad atrophy is the pain response to activity. Plantar fasciitis pain is worst with first steps and improves after warming up. Fat pad atrophy pain is consistent with weight bearing and does not improve — it often worsens — with prolonged walking.
Causes of Plantar Fat Pad Atrophy
- Age — The most common cause. The plantar fat pad progressively loses volume and elasticity beginning around age 40, with significant measurable thinning by age 60–70. The fibrous septae degenerate, the fat cells atrophy, and the pad loses its shock-absorbing architecture.
- Corticosteroid injections — The most iatrogenic (medically caused) form. Injections into or near the plantar fat pad cause fat cell necrosis and fibrous septae disruption, permanently thinning the pad. This is why I never inject directly into the fat pad — only precisely into the plantar fascia — and why limiting injection frequency is important.
- Low body mass / cachexia — Very thin individuals have reduced overall fat stores, including the plantar fat pad
- Rheumatoid arthritis — Systemic inflammation causes metatarsal head prominence and fat pad displacement; this is one of the most common causes of forefoot fat pad atrophy
- High-heeled shoe wear — Chronic high heel use compresses the metatarsal fat pad against the metatarsal heads, promoting atrophy over years
- Diabetes — Glycation of collagen impairs the mechanical properties of the fibrous septae; fat pad thickness is measurably reduced in diabetic patients
- Prior foot surgery — Procedures involving the plantar soft tissue (including sesamoidectomy, Weil osteotomy) can disrupt fat pad architecture
- Chronic plantar fasciitis treatment — Multiple steroid injections for plantar fasciitis are a well-documented cause of iatrogenic fat pad atrophy
Diagnosis
The diagnosis is primarily clinical. Physical examination reveals a thinned, non-compressible fat pad — when I press on a normal fat pad, it feels like a dense cushion; an atrophied pad feels like pressing directly on bone with minimal tissue interposition. Bony prominences may be visible through the skin. Callus patterns help localize which metatarsal heads or heel regions are bearing excess load.
- Ultrasound — Measures fat pad thickness precisely (normal heel pad thickness is approximately 18–20mm in adults; atrophy is typically defined as <10mm). Evaluates echogenicity changes indicating fibrous degeneration. I use ultrasound both diagnostically and to guide precise injection placement.
- MRI — Shows fat pad volume and signal changes, plantar fascia integrity, and other soft tissue pathology. Useful when the diagnosis is uncertain or when evaluating concurrent plantar fasciitis.
- Pedobarography (pressure mapping) — Documents abnormal pressure distribution, identifying which areas are at risk for ulceration in diabetic patients and guiding offloading orthotic design.
Fat Pad Atrophy Treatment
It’s important to understand upfront: we cannot regenerate lost fat pad tissue with any currently available conservative treatment. The goal of management is to replace the function of the lost cushioning with external devices and footwear modifications, and to reduce the mechanical load on the exposed bony prominences.
Cushioning and Offloading (Primary Treatment)
- Heel cups and cushioning insoles — Silicone or viscoelastic heel cups that surround and support the calcaneus, reducing peak plantar pressure and replacing shock absorption. The single most effective intervention for heel fat pad atrophy.
- Metatarsal pads and bars — Positioned proximal to the metatarsal heads, these redistribute forefoot load from the metatarsal heads to the metatarsal shafts, dramatically reducing pain in forefoot fat pad atrophy
- Custom orthotics with total contact accommodation — For severe cases, a total contact orthotic that distributes load across the entire plantar surface provides maximum offloading of vulnerable areas
- Extra-depth diabetic shoes — For diabetic patients, therapeutic footwear with adequate depth accommodates custom orthotics without compressing the toes or forefoot
Recommended Cushioning Products
Emerging Regenerative Treatments
Research into fat pad regeneration is ongoing. Autologous fat grafting — harvesting fat from the patient’s own body (typically the abdomen or thigh) and injecting it into the atrophied plantar region — has shown promising results in small case series, with patients reporting significant pain reduction and improved function. Longer-term outcomes data is limited, and this remains an investigational approach not yet standard of care. Platelet-rich plasma (PRP) injection has also been studied for its potential to stimulate fat pad tissue regeneration; early data is encouraging but not yet definitive.
Frequently Asked Questions: Plantar Fat Pad Atrophy
Can fat pad atrophy be reversed?
With currently available standard treatments, no — the lost fat pad tissue cannot be regenerated conservatively. Autologous fat grafting (surgical fat injection) offers the most promise for tissue restoration but remains investigational. Management focuses on replacing the cushioning function with external devices. The good news is that well-designed orthotics and appropriate footwear can reduce pain dramatically even with significant fat pad loss.
How do I know if I have fat pad atrophy or plantar fasciitis?
The key distinction is the pain pattern. Plantar fasciitis: worst with first steps in the morning, improves after 5–10 minutes of walking, tends to be located at the medial heel. Fat pad atrophy: pain is present throughout weight bearing, does not improve with walking, and is dramatically relieved by cushioning (thick socks, padded shoes, heel cups). An ultrasound measuring fat pad thickness can confirm the diagnosis objectively.
Can steroid injections cause fat pad atrophy?
Yes — this is a well-documented complication of corticosteroid injection into or near the plantar fat pad. Steroids cause fat cell necrosis (cell death) and disruption of the fibrous septae that give the fat pad its structural integrity. The damage is often permanent. This is why responsible practitioners limit injection frequency, use ultrasound guidance to place injections accurately within the plantar fascia rather than the fat pad, and discuss this risk with patients before proceeding.
The Bottom Line
Plantar fat pad atrophy is an underdiagnosed but highly manageable cause of foot pain — especially in older adults, thin individuals, and patients who have had multiple corticosteroid injections in the foot. The diagnosis requires distinguishing it from plantar fasciitis, metatarsalgia, and neuropathy through the characteristic pain pattern and ultrasound measurement. While tissue regeneration remains investigational, excellent functional outcomes are achievable through carefully selected cushioning orthotics, appropriate footwear, and load redistribution strategies. If you’re experiencing severe pain with weight bearing that responds dramatically to cushioning, get evaluated — the right intervention can restore comfortable walking.
Sources
- Waldecker U. “Metatarsalgia in hallux valgus deformity: a pedographic analysis.” Journal of Foot and Ankle Surgery. 2002;41(5):300–308.
- Tong JWK, Kong PW. “Association between foot type and lower extremity injuries: systematic literature review with meta-analysis.” Journal of Orthopaedic & Sports Physical Therapy. 2013;43(10):700–714.
- Espinosa N, et al. “Operative treatment of metatarsophalangeal joint instability.” Foot & Ankle International. 2006;27(3):202–208.
- Abouaesha F, et al. “Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot.” Diabetes Care. 2001;24(7):1270–1274.
Foot Pain With Every Step? Let’s Find the Cause.
Same-day appointments in Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.
- Plantar Fasciitis: Diagnosis and Conservative Management (PubMed)
- Plantar Fasciitis (APMA)
- Diagnosis and Treatment of Plantar Fasciitis (PubMed / AAFP)
- Heel Pain (APMA)